Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 4, Pages 1001
Publisher
MDPI AG
Online
2020-04-21
DOI
10.3390/cells9041001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-ischemic dilated cardiomyopathy and cardiac fibrosis
- (2020) Bianca Olivia Cojan-Minzat et al. HEART FAILURE REVIEWS
- The role of inflammation in stress cardiomyopathy
- (2020) Andra Maria Ciutac et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Road Map for Development of Stem Cell-Based Alternative Test Methods
- (2019) Agapios Sachinidis et al. TRENDS IN MOLECULAR MEDICINE
- Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications
- (2019) Michael Xavier Doss et al. Cells
- Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring
- (2019) Nadine Wenningmann et al. MOLECULAR PHARMACOLOGY
- Applications of miRNAs in cardiac development, disease progression and regeneration
- (2019) Jeremy Kah Sheng Pang et al. Stem Cell Research & Therapy
- MicroRNAs in Inflammatory Heart Diseases and Sepsis-Induced Cardiac Dysfunction: A Potential Scope for the Future?
- (2019) Moritz Mirna et al. Cells
- Liproxstatin-1 protects the mouse myocardium against ischemia/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels
- (2019) Yansheng Feng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Heart failure with preserved ejection fraction: New approaches to diagnosis and management
- (2019) Bharathi Upadhya et al. CLINICAL CARDIOLOGY
- Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies
- (2019) Nanthip Prathumsap et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Role of Myocardial Mitochondrial Quality Control in Heart Failure
- (2019) Zhiling Qiu et al. Frontiers in Pharmacology
- MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients—A Systematic Review
- (2019) Jennifer Y. Barraclough et al. Cells
- Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells
- (2018) Harshal Nemade et al. ARCHIVES OF TOXICOLOGY
- Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients
- (2017) Clarissa Ruggeri et al. HEART FAILURE REVIEWS
- Growth Differentiation Factor-15 Deficiency Augments Inflammatory Response and Exacerbates Septic Heart and Renal Injury Induced by Lipopolysaccharide
- (2017) Palida Abulizi et al. Scientific Reports
- On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death
- (2017) Omkar Zilka et al. ACS Central Science
- Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests
- (2016) Vaibhav Shinde et al. ARCHIVES OF TOXICOLOGY
- MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
- (2016) Umesh Chaudhari et al. ARCHIVES OF TOXICOLOGY
- High throughput physiological screening of iPSC-derived cardiomyocytes for drug development
- (2016) Juan C. del Álamo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Human Embryonic and Induced Pluripotent Stem Cell Based Toxicity Testing Models: Future Applications in New Drug Discovery
- (2016) Vaibhav Shinde et al. CURRENT MEDICINAL CHEMISTRY
- MicroRNAs in heart failure: from biomarker to target for therapy
- (2016) Eline L. Vegter et al. EUROPEAN JOURNAL OF HEART FAILURE
- Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders
- (2016) Yasunori Fujita et al. Geriatrics & Gerontology International
- GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway
- (2016) Yan-Liang Li et al. Oncotarget
- Comparison of a teratogenic transcriptome-based predictive test based on human embryonic versus inducible pluripotent stem cells
- (2016) Vaibhav Shinde et al. Stem Cell Research & Therapy
- Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders
- (2015) Shuichi Yatsuga et al. ANNALS OF NEUROLOGY
- Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment
- (2015) Umesh Chaudhari et al. ARCHIVES OF TOXICOLOGY
- Personalized risk assessment of heart failure patients: More perspectives from transforming growth factor super-family members
- (2015) S. Goletti et al. CLINICA CHIMICA ACTA
- Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction
- (2015) Michelle M.Y. Chan et al. EUROPEAN JOURNAL OF HEART FAILURE
- Neuronal developmental gene and miRNA signatures induced by histone deacetylase inhibitors in human embryonic stem cells
- (2015) K Meganathan et al. Cell Death & Disease
- Cardiac Tissue Engineering
- (2014) Marc N. Hirt et al. CIRCULATION RESEARCH
- Chemically defined generation of human cardiomyocytes
- (2014) Paul W Burridge et al. NATURE METHODS
- Human Stem Cells for Modeling Heart Disease and for Drug Discovery
- (2014) E. Matsa et al. Science Translational Medicine
- High-Throughput Multi-Parameter Profiling of Electrophysiological Drug Effects in Human Embryonic Stem Cell Derived Cardiomyocytes Using Multi-Electrode Arrays
- (2014) Mike Clements et al. TOXICOLOGICAL SCIENCES
- Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity
- (2013) Ping Liang et al. CIRCULATION
- Circulating p53-Responsive MicroRNAs Are Predictive Indicators of Heart Failure After Acute Myocardial Infarction
- (2013) Sen Matsumoto et al. CIRCULATION RESEARCH
- MicroRNAs in Heart Failure: New Targets in Disease Management
- (2013) I Elzenaar et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury
- (2013) Hardip Sandhu et al. CLINICAL SCIENCE
- Heart failure in elderly patients: distinctive features and unresolved issues
- (2013) Valentina Lazzarini et al. EUROPEAN JOURNAL OF HEART FAILURE
- Adaptive Induction of Growth Differentiation Factor 15 Attenuates Endothelial Cell Apoptosis in Response to High Glucose Stimulus
- (2013) Jun Li et al. PLoS One
- Disclosure of grounds of European withdrawn and refused applications: a step forward on regulatory transparency
- (2012) Giovanni Tafuri et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients
- (2012) S. Greco et al. DIABETES
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- Identification of Thalidomide-Specific Transcriptomics and Proteomics Signatures during Differentiation of Human Embryonic Stem Cells
- (2012) Kesavan Meganathan et al. PLoS One
- Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function
- (2012) B. C. Bernardo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cozzarelli Prize Winner: Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling
- (2012) X. Lian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Opportunities for Use of Human iPS Cells in Predictive Toxicology
- (2011) B D Anson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation
- (2011) Elena Matsa et al. EUROPEAN HEART JOURNAL
- Anthracycline cardiotoxicity
- (2011) Pierantonio Menna et al. Expert Opinion On Drug Safety
- Cellular mechanisms of cardiomyopathy
- (2011) Pamela A. Harvey et al. JOURNAL OF CELL BIOLOGY
- Types of Cardiomyocyte Death and Clinical Outcomes in Patients With Heart Failure⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology
- (2011) Sawa Kostin JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiomyocyte death: mechanisms and translational implications
- (2011) M Chiong et al. Cell Death & Disease
- Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality
- (2010) Fredrik E. Wiklund et al. AGING CELL
- Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
- (2010) Lesley A Smith et al. BMC CANCER
- Doxorubicin Cardiomyopathy
- (2009) Kanu Chatterjee et al. CARDIOLOGY
- Inhibition of p53 Transcriptional Activity: A Potential Target for Future Development of Therapeutic Strategies for Primary Demyelination
- (2008) J. Li et al. JOURNAL OF NEUROSCIENCE
- Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity
- (2007) Peter James O’Brien TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started